Low Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid Dependence
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate a very low dose naltrexone-buprenorphine treatment
to transfer opioid dependent individuals to extended release naltrexone injection (Vivitrol).
The hypothesis is that patients will complete the transfer to Vivitrol successfully, finding
the treatment acceptable and showing minimal withdrawal discomfort.
Phase:
Phase 2
Details
Lead Sponsor:
Paolo Mannelli
Collaborator:
Alkermes, Inc.
Treatments:
Analgesics, Opioid Buprenorphine Buprenorphine, Naloxone Drug Combination Naloxone Naltrexone